|
WO2020129986A1
|
|
Botulinum toxin producing method
|
|
WO2020067027A1
|
|
Construction of cho cell line expressing vlp
|
|
WO2020004425A1
|
|
Method for culturing influenza virus
|
|
EP3798185A1
|
|
Aluminum phosphate compound
|
|
TW201938578A
|
|
Enterovirus vaccine
|
|
EP3744829A1
|
|
Medium for culturing pneumococcal samples
|
|
WO2019044636A1
|
|
Method for gradual construction of reassortant influenza virus
|
|
TW201916892A
|
|
Method for producing sterilized viscous base and method for producing medicinal preparation
|
|
WO2018159476A1
|
|
Polyvalent vaccine
|
|
WO2018155051A1
|
|
Lipid a
|
|
US2019300585A1
|
|
Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide
|
|
EP3486316A1
|
|
Reassortant influenza virus production method
|
|
US2019078056A1
|
|
Method for culturing mdck cells
|
|
TW201738257A
|
|
Purification method for target protein
|
|
US2018223326A1
|
|
Method For Measuring Complement-Dependent Bactericidal Function With Respect To Pneumococci
|
|
AU2012227230A1
|
|
Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
|
